‪#‎CBD‬ Drugs, Money... Stock buy? The validation of CBD? A good read on Orphan drug status... The designation provides the drug developer with a seven-year period of U.S. marketing exclusivity upon approval, as well as certain financial incentives that can help support its development. 99.5% pure CBD. So here is how it rolls... #1 The Health and Human resources owns the patent on Cannabinoids. CBD is one cannabinoid. #2 The NIH "National Institute of Health" works the financials between our Govt and the drug company. #3 The FDA "Food and Drug Administration" Covers the health and benefit concerns. YES this is a good thing folks! For me it means that we have the Government of the United States and a publicly traded company validating CBD. I get folks who will ask me Scott how can we trust you on suggesting CBD will help with blah... I always state I can't recommend or suggest anything about CBD, not legal to do. However the facts are presented by the Health and Human resources the National Institute of Health The FDA and several Drug companies including GW Pharmaceutical and Insys Therapeutics that afford us a clearer view into their idea of CBD and how it could work. I can tell you about form factor to the intake method and form factor to the CBD present in the form factor. I can tell you about publicly traded companies who make CBD too. To recommend or suggest? no can do! Again... Good thing the Gov't of The United States is controlling the release of CBD from Cannabis/Marijuana. The companies we represent in reselling CBD come from Cannabis/imported industrialized hemp plants. 

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol for the Treatment of Infantile Spasms